The presence and severity of NAFLD are associated with cognitive impairment and hippocampal damage.

CONTEXT Although cognitive impairment in nonalcoholic fatty liver disease (NAFLD) has received attention in recent years, little is known about detailed cognitive functions in histologically diagnosed individuals. OBJECTIVE This study aimed to investigate the association of liver pathological changes with cognitive features, and further explore the underlying brain manifestations. METHODS AND PATIENTS We performed a cross-sectional study in 320 subjects who underwent liver biopsy. Among the enrolled participants, 225 individuals underwent assessments of global cognition and cognitive subdomains. Furthermore, 70 individuals received functional magnetic resonance imaging (fMRI) scans for neuroimaging evaluations. The associations among liver histological features, brain alterations and cognitive functions were evaluated using structural equation model. RESULTS Compared with controls, patients with NAFLD had poorer immediate memory and delayed memory. Severe liver steatosis (OR = 2.189, 95% CI: 1.020-4.699) and ballooning (OR = 3.655, 95% CI: 1.419 -9.414) was related to a higher proportion of memory impairment. Structural MRI showed that patients with nonalcoholic steatohepatitis exhibited volume loss in left hippocampus and its subregions of subiculum and presubiculum. Task-based MRI showed that patients with nonalcoholic steatohepatitis had decreased left hippocampal activation. Path analysis demonstrated that higher NAFLD activity scores were associated with lower subiculum volume and reduced hippocampal activation, and such hippocampal damage contributed to lower delayed memory scores. CONCLUSION We are the first to report the presence and severity of NAFLD to be associated with an increased risk of memory impairment and hippocampal structural and functional abnormalities. These findings stress the significance of early cognitive evaluation in patients with NAFLD.

[1]  Anne B. Kim,et al.  Insulin resistance, cognition, and Alzheimer disease , 2023, Obesity.

[2]  G. Perseghin,et al.  Diabetes mellitus is associated with higher serum neurofilament light chain levels in the general U.S. population. , 2022, The Journal of clinical endocrinology and metabolism.

[3]  Luping Wang,et al.  Risk of dementia or cognitive impairment in non-alcoholic fatty liver disease: A systematic review and meta-analysis , 2022, Frontiers in Aging Neuroscience.

[4]  F. Underwood,et al.  The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. , 2022, The lancet. Gastroenterology & hepatology.

[5]  Bing Zhang,et al.  Enhancement of Impaired Olfactory Neural Activation and Cognitive Capacity by Liraglutide, but not Dapagliflozin or Acarbose, in Patients With Type 2 Diabetes: A 16-Week Randomized Parallel Comparative Study. , 2022, Diabetes care.

[6]  J. Tardif,et al.  Evaluation of Adiposity and Cognitive Function in Adults , 2022, JAMA network open.

[7]  Y. Yılmaz,et al.  Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver. , 2021, Journal of clinical and translational hepatology.

[8]  R. Simó,et al.  Relationship between Central Obesity and the incidence of Cognitive Impairment and Dementia from Cohort Studies Involving 5,060,687 Participants , 2021, Neuroscience & Biobehavioral Reviews.

[9]  V. Felipo,et al.  A New Score Unveils a High Prevalence of Mild Cognitive Impairment in Patients with Nonalcoholic Fatty Liver Disease , 2021, Journal of clinical medicine.

[10]  V. Wong,et al.  Non-alcoholic fatty liver disease , 2021, The Lancet.

[11]  K. Diers,et al.  Insulin resistance accounts for metabolic syndrome‐related alterations in brain structure , 2021, Human brain mapping.

[12]  K. Duncan,et al.  Children’s family income is associated with cognitive function and volume of anterior not posterior hippocampus , 2020, Nature Communications.

[13]  Naaheed Mukadam,et al.  Dementia prevention, intervention, and care: 2020 report of the Lancet Commission , 2020, The Lancet.

[14]  S. Craft,et al.  Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches , 2020, The Lancet Neurology.

[15]  P. Vuilleumier,et al.  Does inappropriate behavior hurt or stink? The interplay between neural representations of somatic experiences and moral decisions , 2020, Science Advances.

[16]  S. Ikramuddin,et al.  Nonalcoholic Steatohepatitis: A Review. , 2020, JAMA.

[17]  P. Tariot,et al.  Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease , 2019, JAMA neurology.

[18]  S. Fargion,et al.  Brain involvement in non-alcoholic fatty liver disease (NAFLD): A systematic review. , 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[19]  K. Cusi,et al.  Modulation of Insulin Resistance in Nonalcoholic Fatty Liver Disease , 2019, Hepatology.

[20]  Qing X. Yang,et al.  Olfactory Dysfunction Mediates Adiposity in Cognitive Impairment of Type 2 Diabetes: Insights From Clinical and Functional Neuroimaging Studies , 2019, Diabetes Care.

[21]  P. Tariot,et al.  Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease , 2019, The New England journal of medicine.

[22]  P. Calabresi,et al.  Neurofilament light chain as a biomarker in neurological disorders , 2019, Journal of Neurology, Neurosurgery, and Psychiatry.

[23]  O. Franco,et al.  C-Reactive Protein, Plasma Amyloid-&bgr; Levels, and Their Interaction With Magnetic Resonance Imaging Markers , 2018, Stroke.

[24]  V. Gudnason,et al.  Genetic overlap between vascular pathologies and Alzheimer's dementia and potential causal mechanisms , 2018, Alzheimer's & Dementia.

[25]  Aad van der Lugt,et al.  Subregional volumes of the hippocampus in relation to cognitive function and risk of dementia , 2018, NeuroImage.

[26]  Qing X. Yang,et al.  Altered Odor-Induced Brain Activity as an Early Manifestation of Cognitive Decline in Patients With Type 2 Diabetes , 2018, Diabetes.

[27]  O. Markovic,et al.  Cognitive Changes and Brain Volume Reduction in Patients with Nonalcoholic Fatty Liver Disease , 2018, Canadian journal of gastroenterology & hepatology.

[28]  G. Marchesini,et al.  Reactive hyperemia index (RHI) and cognitive performance indexes are associated with histologic markers of liver disease in subjects with non-alcoholic fatty liver disease (NAFLD): a case control study , 2018, Cardiovascular Diabetology.

[29]  C. Byrne,et al.  Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus , 2018, Nature Reviews Endocrinology.

[30]  C. Cervellati,et al.  Low-grade systemic inflammation is associated with functional disability in elderly people affected by dementia , 2018, GeroScience.

[31]  D. Foguel,et al.  Age-related cognitive impairment is associated with long-term neuroinflammation and oxidative stress in a mouse model of episodic systemic inflammation , 2018, Journal of Neuroinflammation.

[32]  Steven E. Arnold,et al.  Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums , 2018, Nature Reviews Neurology.

[33]  E. Feldman,et al.  Neurological consequences of obesity , 2017, The Lancet Neurology.

[34]  C. Lewis,et al.  Nonalcoholic Fatty Liver Disease and Measures of Early Brain Health in Middle Aged Adults: The CARDIA study , 2016, Obesity.

[35]  S. Francque,et al.  Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications. , 2016, Journal of hepatology.

[36]  Jeanne M. Clark,et al.  Nonalcoholic fatty liver disease is associated with cognitive function in adults , 2016, Neurology.

[37]  E. Maguire,et al.  Anterior hippocampus: the anatomy of perception, imagination and episodic memory , 2016, Nature Reviews Neuroscience.

[38]  O. Garaschuk,et al.  Neuroinflammation in Alzheimer's disease , 2015, The Lancet Neurology.

[39]  K. Langa,et al.  The diagnosis and management of mild cognitive impairment: a clinical review. , 2014, JAMA.

[40]  S. Spencer,et al.  Named Series : Diet , Inflammation and the Brain Obesity and neuroinflammation : A pathway to cognitive impairment , 2014 .

[41]  V Shane Pankratz,et al.  A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment. , 2014, JAMA neurology.

[42]  Chunbo Li,et al.  Reliability and validity of the Repeatable Battery for the Assessment of Neuropsychological Status in community-dwelling elderly , 2011, Archives of medical science : AMS.

[43]  B. Neuschwander‐Tetri,et al.  Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings , 2011, Hepatology.

[44]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[45]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[46]  R. Karim,et al.  NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome , 2002, Hepatology.

[47]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[48]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[49]  R. Vasan,et al.  Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study , 2018, JAMA neurology.

[50]  S. Fargion,et al.  Subclinical cerebrovascular disease in NAFLD without overt risk factors for atherosclerosis. , 2018, Atherosclerosis.

[51]  Xiaoyu Sun,et al.  Olfactory cortex degeneration in Alzheimer's disease and mild cognitive impairment. , 2015, Journal of Alzheimer's disease : JAD.